Skip to Content

Lumigan Side Effects

Generic Name: bimatoprost ophthalmic

Note: This page contains information about the side effects of bimatoprost ophthalmic. Some of the dosage forms included on this document may not apply to the brand name Lumigan.

Not all side effects for Lumigan may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

For the Consumer

Applies to bimatoprost ophthalmic: ophthalmic solution

In addition to its needed effects, some unwanted effects may be caused by bimatoprost ophthalmic (the active ingredient contained in Lumigan). In the event that any of these side effects do occur, they may require medical attention.

You should check with your doctor immediately if any of these side effects occur when taking bimatoprost ophthalmic:

Less common
  • Blindness
  • bloody eye
  • blurred or decreased vision
  • change in color vision
  • color changes in the skin around the eyes
  • difficulty seeing at night
  • disturbed color perception
  • double vision
  • dry eyes
  • eye color changes
  • fever or chills
  • halos around lights
  • lack or loss of strength
  • loss of vision
  • night blindness
  • overbright appearance of lights
  • redness, burning, dry, or itching eyes
  • redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid
  • tunnel vision

Some of the side effects that can occur with bimatoprost ophthalmic may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

More common
  • Body aches or pain
  • cough
  • difficulty with breathing
  • ear congestion
  • headache
  • loss of voice
  • nasal congestion
  • redness of the white part of eyes or inside of the eyelids
  • runny nose
  • sneezing
  • sore throat
  • unusual tiredness or weakness
Less common
  • Darkening of the eyelashes
  • eye discharge or excessive tearing
  • eye strain
  • feeling of having something in the eye
  • increase in hair growth
  • increased sensitivity of the eyes to sunlight

For Healthcare Professionals

Applies to bimatoprost ophthalmic: ophthalmic solution


Very common (10% or more): Conjunctival hyperemia, ocular pruritus, growth of eyelashes
Common (1% to 10%): Superficial punctate keratitis, corneal erosion, ocular burning, ocular irritation, allergic conjunctivitis, blepharitis, worsening of visual acuity, asthenopia, conjunctival edema, foreign body sensation, ocular dryness, eye pain, photophobia, tearing, eye discharge, visual disturbance/blurred vision, increased iris pigmentation, eyelash darkening, eyelid erythema, eyelid pruritus
Uncommon (0.1% to 1%): Retinal hemorrhage, uveitis, cystoid macular edema, iritis, blepharospasm, eyelid retraction, periorbital erythema, eyelid edema
Very rare (less than 0.01%): Corneal calcification (in association with the use of phosphate containing eye drops in some patients with significantly damaged corneas)
Frequency not reported: Enophthalmos
Postmarketing reports: Increased lacrimation, skin discoloration (periorbital)[Ref]


Common (1% to 10%): Pigmentation of periocular skin
Uncommon (0.1% to 1%): Hirsutism
Frequency not reported: Abnormal hair growth
Postmarketing reports: Trichorrhexis, madarosis[Ref]


Frequency not reported: Asthma, asthma exacerbation, COPD exacerbation, dyspnea, upper respiratory tract infections, cold[Ref]

Nervous system

Common (1% to 10%): Headache
Uncommon (0.1% to 1%): Dizziness, vertigo[Ref]


Common (1% to 10%): Abnormal liver function test[Ref]


Uncommon (0.1% to 1%): Asthenia[Ref]


Common (1% to 10%): Hypertension[Ref]


Uncommon (0.1% to 1%): Nausea[Ref]


The most frequently reported adverse reaction was conjunctival hyperemia.[Ref]


Postmarketing reports: Hypersensitivity[Ref]


Uncommon (0.1% to 1%): Depression[Ref]


1. Cerner Multum, Inc. "Australian Product Information." O 0

2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

3. "Product Information. Lumigan (bimatoprost ophthalmic)" Allergan Inc, Irvine, CA.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.